To be successful going forward in creating more resiliency here in Canada, the government needs to create conditions that foster innovation and support investment. We are competing on a global stage and are apparently woefully behind our peers. We need to start with incremental support of the life sciences sector by leveraging the strength of discovery and research to build on the rest of the ecosystem. This includes the role that industry plays in providing its manufacturing expertise and managing global supply change.
An understanding that local market and regulatory conditions do impact and determine our resiliency here in Canada is fundamental. Some of the lessons we have learned from what has taken place during this pandemic is that years of public policy decisions have made Canada less attractive to investment. PMPRB's flawed regulatory changes impede domestic companies from scaling up without artificial support. There are slow drug listings and processes that have limited or delayed access to new medicine. There's mediocre IP protection.
All of this has taken place without a sincere and collaborative consultation with our industry. As I mentioned in my opening statement, we're here and available to help solve this problem collectively.